Seronegative Myasthenia Gravis (SNMG) presents a diagnostic and therapeutic conundrum in the field of neurology. This review delves into the intricacies of SNMG, shedding light on the complexities of its diagnosis and management. While conventional diagnostic markers may not be present in SNMG patients, emerging research has unveiled potential alternative diagnostic methods. Moreover, the management of SNMG poses unique challenges, necessitating a tailored approach for each patient. This review explores the current state of knowledge, highlighting both the advances and remaining uncertainties in the realm of SNMG.
HTML PDFShare this article
Epilepsy Journal received 41 citations as per Google Scholar report
